(F4) Treatment of high risk myelodysplastic syndromes with sequential intermediate dose cytosine arabinoside and mitoxantrone (S-HAM) with or without GM-CSF: A prospective double blinded randomised study

✍ Scribed by W Hiddemann; T.H. Buchner; B Wormann; P Koch; C Aul; M Andreeff; J.M. Bennett

• Book ID: 113239454
• Publisher: Elsevier Science
• Year: 1991
• Tongue: English
• Weight: 154 KB
• Volume: 15
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/0145-2126(91)90373-2